JP2009534405A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009534405A5 JP2009534405A5 JP2009506741A JP2009506741A JP2009534405A5 JP 2009534405 A5 JP2009534405 A5 JP 2009534405A5 JP 2009506741 A JP2009506741 A JP 2009506741A JP 2009506741 A JP2009506741 A JP 2009506741A JP 2009534405 A5 JP2009534405 A5 JP 2009534405A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- och
- nhch
- coch
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 31
- 150000001875 compounds Chemical class 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 7
- 239000011780 sodium chloride Substances 0.000 claims 7
- 239000012453 solvate Substances 0.000 claims 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- -1 -OR a Chemical group 0.000 claims 5
- 125000000623 heterocyclic group Chemical class 0.000 claims 4
- 125000003831 tetrazolyl group Chemical group 0.000 claims 4
- 150000004677 hydrates Chemical class 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000004193 piperazinyl group Chemical group 0.000 claims 2
- URSPTJYSBTXILH-UHFFFAOYSA-N 1-methylidenepiperazin-1-ium-4-ide Chemical group C=[N+]1CC[N-]CC1 URSPTJYSBTXILH-UHFFFAOYSA-N 0.000 claims 1
- 206010003246 Arthritis Diseases 0.000 claims 1
- 206010003816 Autoimmune disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 1
- 206010040767 Sjogren's syndrome Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 125000000392 cycloalkenyl group Chemical class 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 201000002674 obstructive nephropathy Diseases 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical class 0.000 claims 1
- 201000004681 psoriasis Diseases 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 125000005942 tetrahydropyridyl group Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical class 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
- 0 CC(*)(CC1(*)*)CC(*)(*)S1(=O)=O Chemical compound CC(*)(CC1(*)*)CC(*)(*)S1(=O)=O 0.000 description 5
- GDPCTEDCXWLRRP-UHFFFAOYSA-N CC(C)(CC1)CC=C1c(cc(C(CC1)(CCN1C(C)=O)O)cc1)c1NC(c1nc(CN=C)c[nH]1)=O Chemical compound CC(C)(CC1)CC=C1c(cc(C(CC1)(CCN1C(C)=O)O)cc1)c1NC(c1nc(CN=C)c[nH]1)=O GDPCTEDCXWLRRP-UHFFFAOYSA-N 0.000 description 1
- WQMPQQWLDADXRU-UHFFFAOYSA-N CC(C)(CC1)CC=C1c(cc(C1(CCOCC1)S(C)(=O)=O)cc1)c1NC(c1ncc(C#N)[nH]1)=O Chemical compound CC(C)(CC1)CC=C1c(cc(C1(CCOCC1)S(C)(=O)=O)cc1)c1NC(c1ncc(C#N)[nH]1)=O WQMPQQWLDADXRU-UHFFFAOYSA-N 0.000 description 1
- MPIHCDRUDLIBHE-UHFFFAOYSA-N CC(C)(CC1)CC=C1c(nc(C1(CCOCC1)O)cc1)c1NC(c1nc(NC)c[nH]1)=O Chemical compound CC(C)(CC1)CC=C1c(nc(C1(CCOCC1)O)cc1)c1NC(c1nc(NC)c[nH]1)=O MPIHCDRUDLIBHE-UHFFFAOYSA-N 0.000 description 1
Claims (10)
- 式I
Wは、
各R4は、独立して、H、F、Cl、Br、I、OH、OCH3、OCH2CH3、SC(1-4)アルキル、SOC(1-4)アルキル、SO2C(1-4)アルキル、−C(1-3)アルキル、CO2Rd、CONReRf、C≡CRgまたはCNであり;かつ
Rdは、Hまたは−C(1-3)アルキルであり;
Reは、Hまたは−C(1-3)アルキルであり;
Rfは、Hまたは−C(1-3)アルキルであり;そして
Rgは、H、−CH2OHまたは−CH2CH2OHであり;
R2は、シクロアルキル、スピロ置換シクロアルケニル、ヘテロシクリル、スピロ置換ピペリジニル、チオフェニル、ジヒドロスルホノピラニル、フェニル、フラニル、テトラヒドロピリジルまたはジヒドロピラニルであり、これらはいずれも独立して下記:クロロ、フルオロ、ヒドロキシ、C(1-3)アルキルおよびC(1-4)アルキルの各々の1または2個で置換されていてもよく;
Zは、H、FまたはCH3であり;
Jは、CHまたはNであり;
Xは、
R1は、−C(1-4)アルキル、−ORa、−CN、−NA1A2、−SO2CH3、−COORa、−CO2CH3、−CH2−NA1A2、−CONA1A2、−CH2ORa、−OC(1-4)アルキルORa、−NHCH2CH2CO2Ra、−NHCH2CH2ORa、−NRaCH2CH2NA1A2、−OC(1-4)アルキルNA1A2、−OCH2CO2Ra、−CH2CO2Ra、−CH2CH2SO2C(1-4)アルキル、−SO2CH2CH2NA1A2、−SOCH2CH2NA1A2、−SCH2CH2NA1A2、−NHSO2CH2CH2NA1A2、フェニル、イミダゾリル、チアゾリル、4H−[1,2,4]オキサジアゾール−5−オニル、4H−ピロロ[2,3−b]ピラジニル、ピリジニル、[1,3,4]オキサジアゾリル、4H−[1,2,4]トリアゾリル、テトラゾリル、ピラゾリル、[1,3,5]トリアジニルまたは[1,3,4]チアジアゾリルであり;
RzおよびRyは、独立して、Hまたは−C(1-4)アルキルであり、かつ両方のRzがシンまたはアンチ立体化学のいずれかを有していてもよいか;あるいは、シン関係にある両方のRzが一緒になって-(CH2)n−を形成していてもよく、かつnは2または
3であり;
R3は、H、C(1-4)アルキル、C(1-3)アルキル−CF3、CH2CH2NH2、CH2CH2ORa、−COCH3、CONH2またはCO2Raであり;
A1は、H、-C(1-4)アルキルまたはCH2CH2ORaであり;
A2は、H、-C(1-4)アルキル、CORa、CH2CON(CH3)2、−CH2
CH2ORa、−CH2CH2SC(1-4)アルキル、−CH2CH2SOC(1-4)アルキルまたは−CH2CH2SO2C(1-4)アルキルであるか;あるいは
A1とA2がこれらの結合している窒素と一緒になって下記:
Raは、HまたはC(1-4)アルキルであり;
Raaは、HまたはC(1-4)アルキルであり;そして
Rbbは、H、-C(1-4)アルキル、−CH2CH2OCH2CH2OCH3、−C
H2CO2H、−C(O)C(1-4)アルキルまたは−CH2C(O)C(1-4)アルキルである]
で表される新規な化合物または該化合物の溶媒和物、水化物、互変異性体もしくは製薬学的に許容される塩。 - Wが
R2が
ZがHであり;
Xが
R1が−OH、−CN、−NA1A2、−SO2CH3、−COORa、−CO2CH3、−CH2−NA1A2、−CONA1A2、−CH2ORa、−NHCH2CH2CO2Ra、−NHCH2CH2ORa、−NHCH2CH2NA1A2、−OC(1-4)アルキルNA1A2、−OCH2CO2Raまたはテトラゾリルであり;
A1がHまたは−CH3であり;
A2がH、−CH2CH2OCH3、−COCH3または−CH3であるか;あるいは
A1とA2がこれらの結合している窒素と一緒になって下記:
RaがHまたは−C(1-4)アルキルであり;
RaaがHまたは−C(1-4)アルキルであり;
RbbがH、-C(1-4)アルキル、−CH2CO2Hまたは−COCH3であり;
RyがHまたは-CH3であり;
RzがH、−CH3であるか、または-CH2CH2−として一緒になっていてもよく;
R3がH、−CH2CF3、−COCH3、−CH3、−CO2CH3、−CONH2または−CO2Hである;
請求項1記載の化合物または該化合物の溶媒和物、水化物、互変異性体もしくは製薬学的に許容される塩。 - R2が
Xが
R1が−OH、−CN、−NA1A2、−SO2CH3、−COOH、−CO2CH3、−CH2−NA1A2、−CONH2、−CON(CH3)2、−CH2OH、−OCH2CH2N(CH3)2、−NHCH2CH2CO2CH3、−NHCH2CH2OCH3、−NHCH2CH2NA1A2、−OC(1-4)アルキルNA1A2、−OCH2CO2Hまたはテトラゾリルであり;
A1がHまたは−CH3であり;
A2がH、−CH2CH2OCH3、−COCH3または−CH3であるか;あるいは
A1とA2がこれらの結合している窒素と一緒になって下記:
RbbがH、-C(1-4)アルキル、−CH2CO2Hまたは−COCH3であり;
RyがHまたは-CH3であり;
RzがH、−CH3であるか、または-CH2CH2−として一緒になっていてもよく;
R3がH、−CH2CF3、−COCH3、−CH3、−CO2CH3、−CONH2または−CO2Hである;
請求項2記載の化合物ばかりでなくこれの溶媒和物、水化物、互変異性体および製薬学的に許容される塩。 - 請求項1記載の化合物および製薬学的に許容される担体を含有して成る製薬学的組成物。
- 請求項1記載の少なくとも1種の化合物を有効成分として含んでなる哺乳動物における炎症を治療するための製薬学的製剤。
- 請求項1記載の少なくとも1種の化合物を有効成分として含んでなる自己免疫病、例えば全身性エリテマトーデス、関節リウマチおよび他の形態の炎症性関節炎、乾癬、シェーグレン症候群、多発性硬化症またはブドウ膜炎を治療するための製薬学的製剤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79366706P | 2006-04-20 | 2006-04-20 | |
US60/793,667 | 2006-04-20 | ||
PCT/US2007/066868 WO2007124319A1 (en) | 2006-04-20 | 2007-04-18 | Inhibitors of c-fms kinase |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009534405A JP2009534405A (ja) | 2009-09-24 |
JP2009534405A5 true JP2009534405A5 (ja) | 2010-05-13 |
JP5331679B2 JP5331679B2 (ja) | 2013-10-30 |
Family
ID=38472852
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009506744A Expired - Fee Related JP5331681B2 (ja) | 2006-04-20 | 2007-04-18 | c−fmsキナーゼの阻害剤 |
JP2009506742A Expired - Fee Related JP5331680B2 (ja) | 2006-04-20 | 2007-04-18 | c−fmsキナーゼの阻害剤 |
JP2009506741A Expired - Fee Related JP5331679B2 (ja) | 2006-04-20 | 2007-04-18 | c−fmsキナーゼの阻害剤 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009506744A Expired - Fee Related JP5331681B2 (ja) | 2006-04-20 | 2007-04-18 | c−fmsキナーゼの阻害剤 |
JP2009506742A Expired - Fee Related JP5331680B2 (ja) | 2006-04-20 | 2007-04-18 | c−fmsキナーゼの阻害剤 |
Country Status (23)
Country | Link |
---|---|
US (7) | US8859602B2 (ja) |
EP (3) | EP2016058B1 (ja) |
JP (3) | JP5331681B2 (ja) |
KR (3) | KR101491564B1 (ja) |
CN (1) | CN101472914B (ja) |
AR (3) | AR060611A1 (ja) |
AU (3) | AU2007240440B2 (ja) |
BR (1) | BRPI0710548B8 (ja) |
CA (3) | CA2649739C (ja) |
ES (3) | ES2564781T3 (ja) |
HK (1) | HK1133878A1 (ja) |
IL (1) | IL194845A (ja) |
MX (3) | MX2008013529A (ja) |
NO (1) | NO20084896L (ja) |
NZ (3) | NZ572070A (ja) |
PE (1) | PE20080074A1 (ja) |
RU (1) | RU2475483C2 (ja) |
SG (1) | SG171593A1 (ja) |
TW (3) | TW200815415A (ja) |
UA (1) | UA93085C2 (ja) |
UY (1) | UY30297A1 (ja) |
WO (3) | WO2007124321A1 (ja) |
ZA (1) | ZA200809873B (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060281788A1 (en) * | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor |
WO2007081879A2 (en) * | 2006-01-05 | 2007-07-19 | Novartis Ag | Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
US8697716B2 (en) * | 2006-04-20 | 2014-04-15 | Janssen Pharmaceutica Nv | Method of inhibiting C-KIT kinase |
KR101448052B1 (ko) * | 2006-04-20 | 2014-10-07 | 얀센 파마슈티카 엔.브이. | C-kit 키나아제 억제 방법 |
EP2687516A1 (en) * | 2006-04-20 | 2014-01-22 | Janssen Pharmaceutica N.V. | Inhibitors of C-FMS Kinase |
WO2007124316A1 (en) | 2006-04-20 | 2007-11-01 | Janssen Pharmaceutica N.V. | Heterocyclic compounds as inhibitors of c-fms kinase |
KR101491564B1 (ko) * | 2006-04-20 | 2015-02-09 | 얀센 파마슈티카 엔.브이. | C-fms 키나제의 저해제 |
JO3240B1 (ar) * | 2007-10-17 | 2018-03-08 | Janssen Pharmaceutica Nv | c-fms مثبطات كيناز |
US10106798B2 (en) | 2010-01-05 | 2018-10-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | FLT3 receptor antagonists for the treatment or the prevention of pain disorders |
WO2011083124A1 (en) * | 2010-01-05 | 2011-07-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Flt3 receptor antagonists for the treatment or the prevention of pain disorders |
MX347616B (es) | 2011-05-05 | 2017-05-04 | Sloan-Kettering Institute For Cancer Res | Inhibidores de csf-1r para el tratamiento de tumores de cerebro. |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
JP6359537B2 (ja) | 2012-08-07 | 2018-07-18 | ヤンセン ファーマシューティカ エヌ.ベー. | 複素環エステル誘導体の調製プロセス |
JOP20180012A1 (ar) | 2012-08-07 | 2019-01-30 | Janssen Pharmaceutica Nv | عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد |
SG11201602445SA (en) | 2013-10-04 | 2016-04-28 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and uses thereof |
WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
CA2938311C (en) * | 2014-02-03 | 2023-03-07 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ror-gamma |
WO2015143012A1 (en) | 2014-03-19 | 2015-09-24 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
NZ740616A (en) | 2015-09-14 | 2023-05-26 | Infinity Pharmaceuticals Inc | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
WO2021144360A1 (en) | 2020-01-17 | 2021-07-22 | F. Hoffmann-La Roche Ag | Small molecule csf-1r inhibitors in therapeutic and cosmetic uses |
CN112441941B (zh) * | 2020-12-03 | 2022-08-02 | 浙江荣耀生物科技股份有限公司 | 一种1-(4-氨基苯基)环戊基甲腈的制备方法 |
Family Cites Families (138)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2466420A (en) * | 1947-11-26 | 1949-04-05 | Eastman Kodak Co | Ketene condensation products with aldehydes |
US3226394A (en) | 1964-06-16 | 1965-12-28 | Shulton Inc | Pyridylethylated anthranilamides and derivatives thereof |
CH504416A (de) | 1966-12-05 | 1971-03-15 | Ciba Geigy Ag | Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen |
US4551540A (en) * | 1983-01-17 | 1985-11-05 | Borg-Warner Chemicals, Inc. | Substituted 2,5-dimethylpyrroles |
JPH0264704A (ja) | 1988-08-30 | 1990-03-05 | Honda Motor Co Ltd | 自動化設備の制御システム |
EP0358459B1 (en) * | 1988-09-08 | 1996-06-19 | Sony Corporation | Picture processing apparatus |
JPH0299250A (ja) | 1988-09-30 | 1990-04-11 | Kobe Steel Ltd | タンディッシュのスラグ除去方法 |
JP2833106B2 (ja) | 1990-02-21 | 1998-12-09 | 株式会社島津製作所 | 液体クロマトグラフ |
JPH03255915A (ja) | 1990-03-07 | 1991-11-14 | Nkk Corp | 流量検出装置 |
US5190541A (en) | 1990-10-17 | 1993-03-02 | Boston Scientific Corporation | Surgical instrument and method |
JPH04184937A (ja) | 1990-11-20 | 1992-07-01 | Oki Electric Ind Co Ltd | 半導体集積回路装置の製造方法 |
JPH04212503A (ja) | 1990-12-05 | 1992-08-04 | Mitsubishi Electric Corp | トリプレート線路共振器 |
JPH0821207B2 (ja) | 1992-02-03 | 1996-03-04 | 日本コロムビア株式会社 | ディスク装置 |
AU3737893A (en) | 1992-03-05 | 1993-10-05 | Board Of Regents, The University Of Texas System | Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
US5474765A (en) | 1992-03-23 | 1995-12-12 | Ut Sw Medical Ctr At Dallas | Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells |
JPH05293265A (ja) | 1992-04-17 | 1993-11-09 | Juki Corp | 千鳥縫いミシンの針振り駆動変更装置 |
JPH0815587B2 (ja) | 1992-05-01 | 1996-02-21 | 東亜工業株式会社 | 振動ふるい |
JPH05346639A (ja) | 1992-06-15 | 1993-12-27 | Konica Corp | 写真処理廃液の再利用方法 |
JPH0684710A (ja) | 1992-09-03 | 1994-03-25 | Matsushita Electric Ind Co Ltd | 電解コンデンサ |
US5686472A (en) | 1992-10-29 | 1997-11-11 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
JP3243861B2 (ja) | 1992-12-10 | 2002-01-07 | ソニー株式会社 | 画像情報変換装置 |
KR100360206B1 (ko) * | 1992-12-10 | 2003-02-11 | 소니 가부시끼 가이샤 | 화상신호변환장치 |
JPH06189231A (ja) * | 1992-12-16 | 1994-07-08 | Toshiba Corp | 液晶表示装置 |
JP3522818B2 (ja) | 1993-02-26 | 2004-04-26 | 富士写真フイルム株式会社 | 写真用支持体 |
US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
JP3192537B2 (ja) | 1993-11-18 | 2001-07-30 | キヤノン株式会社 | 走査光学装置 |
JP3197737B2 (ja) | 1994-02-15 | 2001-08-13 | 三洋電機株式会社 | コインメカニズムの取付け装置 |
JPH07310319A (ja) | 1994-05-19 | 1995-11-28 | Katsuyuki Hasegawa | 杭打ち装置及び杭打ちアタッチメント |
JP3592748B2 (ja) | 1994-07-01 | 2004-11-24 | 三菱重工業株式会社 | 蒸気、ガスタービン複合プラントの廃熱による蒸気生成システム |
JPH08107715A (ja) | 1994-10-13 | 1996-04-30 | Iseki & Co Ltd | コンバインの拡縮式グレンタンク装置 |
EP0785937A1 (en) | 1994-10-14 | 1997-07-30 | Smithkline Beecham Plc | 2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials |
JP3357754B2 (ja) | 1994-10-18 | 2002-12-16 | 三洋電機株式会社 | 疑似ステレオ画像生成方法及び疑似ステレオ画像生成装置 |
JPH08287118A (ja) | 1995-02-16 | 1996-11-01 | Fujitsu Ltd | 部品標準化方式 |
JPH07322944A (ja) | 1995-04-10 | 1995-12-12 | Sanyo Electric Co Ltd | 透視板 |
BR9608021A (pt) | 1995-04-19 | 1999-03-02 | Schneider Inc | Dispositivo expansível revestido de libertação de droga |
US6117432A (en) * | 1995-04-20 | 2000-09-12 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
JP3415333B2 (ja) | 1995-07-13 | 2003-06-09 | トヨタ自動車株式会社 | 水素吸蔵合金 |
TW349948B (en) | 1995-10-31 | 1999-01-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 2-quinolone derivatives |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
EP1162201B1 (en) * | 1995-12-08 | 2006-03-29 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
US5874442A (en) * | 1995-12-22 | 1999-02-23 | Schering-Plough Corporation | Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease |
US6011029A (en) | 1996-02-26 | 2000-01-04 | Bristol-Myers Squibb Company | Inhibitors of farnesyl protein transferase |
US5702390A (en) | 1996-03-12 | 1997-12-30 | Ethicon Endo-Surgery, Inc. | Bioplar cutting and coagulation instrument |
AU711936B2 (en) | 1996-08-09 | 1999-10-28 | Banyu Pharmaceutical Co., Ltd. | Stereoselective deoxygenation reaction |
DE69725604T2 (de) | 1996-12-20 | 2005-03-03 | Sergazy Mynzhasarovich Adekenov | VERFAHREN UND GERÄT ZUR HERSTELLUNG VPM LYOPHILISIERTEM 1ß, 10ß-EPOXY-13-DIMETHYLAMINO-GUAIA-3(4)-EN-6,12-OLID-HYDROCHLORID |
UA59384C2 (uk) | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
TW591030B (en) | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
IL130363A (en) | 1997-04-25 | 2002-08-14 | Janssen Pharmaceutica Nv | Quinazolines that inhibit frenzyl transferase, their preparation and pharmaceutical preparations containing them |
TW491872B (en) | 1997-05-27 | 2002-06-21 | Ciba Sc Holding Ag | Block oligomers containing l-hydrocarbyloxy-2,2,6,6-tetramethyl-4- piperidyl groups as stabilizers for lower polyolefin |
US6100254A (en) * | 1997-10-10 | 2000-08-08 | Board Of Regents, The University Of Texas System | Inhibitors of protein tyrosine kinases |
DE69902012T2 (de) | 1998-03-05 | 2002-11-21 | Formula One Administration Ltd | Datenübertragungssystem |
US6303654B1 (en) | 1998-03-12 | 2001-10-16 | Wisconsin Alumni Research Foundation | Acyclic monoterpenoid derivatives |
WO2000001691A1 (en) | 1998-07-01 | 2000-01-13 | Merck & Co., Inc. | Process for making farnesyl-protein transferase inhibitors |
AU747427B2 (en) | 1998-07-10 | 2002-05-16 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
US6284098B1 (en) * | 1998-07-20 | 2001-09-04 | Wwj, Llc | Lignocellulose fiber filler for thermoplastic composite compositions |
NZ509372A (en) | 1998-08-27 | 2003-08-29 | Pfizer Prod Inc | Substituted quinolin-2-one derivatives, pharmaceuticals thereof and their use for treating abnormal cell growth (e.g. cancer) |
ATE289602T1 (de) | 1998-08-27 | 2005-03-15 | Pfizer Prod Inc | Quinolin-2-on-derivate verwendbar als antikrebsmittel |
GB9824579D0 (en) * | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
AU765437B2 (en) * | 1998-12-23 | 2003-09-18 | Janssen Pharmaceutica N.V. | 1,2-annelated quinoline derivatives |
ES2206191T3 (es) * | 1999-01-11 | 2004-05-16 | Princeton University | Inhibidores de alta afinidad para validacion de dianas y usos de los mismos. |
EP2308833A3 (en) | 1999-04-15 | 2011-09-28 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
WO2000064946A2 (en) | 1999-04-28 | 2000-11-02 | Board Of Regents, The University Of Texas System | Compositions and methods for cancer treatment by selectively inhibiting vegf |
JP3766231B2 (ja) | 1999-05-10 | 2006-04-12 | Necビューテクノロジー株式会社 | 液晶表示装置 |
US6346625B1 (en) | 1999-06-23 | 2002-02-12 | Astrazeneca Ab | Protein kinase inhibitors |
DE60040786D1 (de) * | 1999-08-05 | 2008-12-24 | Sanyo Electric Co | Bildinterpolationsverfahren |
JP2001078113A (ja) * | 1999-09-06 | 2001-03-23 | Sony Corp | 映像機器および映像表示方法 |
US6852752B2 (en) * | 1999-12-17 | 2005-02-08 | Vicuron Pharmaceuticals Inc. | Urea compounds, compositions and methods of use and preparation |
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
JP4794793B2 (ja) | 1999-12-28 | 2011-10-19 | ファーマコペイア, インコーポレイテッド | N−ヘテロ環TNF−α発現阻害剤 |
FR2803592A1 (fr) * | 2000-01-06 | 2001-07-13 | Aventis Cropscience Sa | Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant. |
GB0005357D0 (en) | 2000-03-06 | 2000-04-26 | Smithkline Beecham Plc | Compounds |
US6558385B1 (en) | 2000-09-22 | 2003-05-06 | Tissuelink Medical, Inc. | Fluid-assisted medical device |
US6692491B1 (en) | 2000-03-24 | 2004-02-17 | Scimed Life Systems, Inc. | Surgical methods and apparatus for positioning a diagnostic or therapeutic element around one or more pulmonary veins or other body structures |
US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
JP4150947B2 (ja) * | 2000-08-23 | 2008-09-17 | ソニー株式会社 | 画像処理装置および方法、並びに記録媒体 |
WO2002032861A2 (en) | 2000-10-17 | 2002-04-25 | Merck & Co., Inc. | Orally active salts with tyrosine kinase activity |
US7105682B2 (en) | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
AR035885A1 (es) | 2001-05-14 | 2004-07-21 | Novartis Ag | Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica |
US7101884B2 (en) | 2001-09-14 | 2006-09-05 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
WO2003024931A1 (en) | 2001-09-14 | 2003-03-27 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
TWI259081B (en) | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
ATE335490T1 (de) | 2001-10-30 | 2006-09-15 | Novartis Pharma Gmbh | Staurosporin-derivate als hemmer der flt3- rezeptor-tyrosinkinase-wirkung |
NZ533219A (en) | 2001-12-27 | 2005-10-28 | Theravance Inc | Indolinone derivatives useful as protein kinase inhibitors |
JP4218249B2 (ja) * | 2002-03-07 | 2009-02-04 | 株式会社日立製作所 | 表示装置 |
CN100558715C (zh) | 2002-05-23 | 2009-11-11 | 西托匹亚有限公司 | 蛋白激酶抑制剂 |
PE20040522A1 (es) | 2002-05-29 | 2004-09-28 | Novartis Ag | Derivados de diarilurea dependientes de la cinasa de proteina |
MY141867A (en) * | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
GB0215676D0 (en) | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
EP1546117A2 (en) | 2002-08-14 | 2005-06-29 | Vertex Pharmaceuticals Incorporated | Protein kinase inhibitors and uses thereof |
BR0313743A (pt) | 2002-08-23 | 2005-07-05 | Chiron Corp | Benzimidazol quinolinonas e usos destas |
WO2004022525A1 (en) | 2002-09-05 | 2004-03-18 | Neurosearch A/S | Amide derivatives and their use as chloride channel blockers |
KR20050056227A (ko) | 2002-10-03 | 2005-06-14 | 탈자진 인코포레이티드 | 혈관항상성 유지제 및 그의 사용 방법 |
EP1566379A4 (en) | 2002-10-29 | 2005-11-09 | Kirin Brewery | QUINOLINE AND QUINAZOLINE DERIVATIVES INHIBITING THE AUTOPHOSPHORYLATION OF FLT3 AND MEDICAL COMPOSITIONS CONTAINING SAME |
NZ539425A (en) | 2002-11-13 | 2007-11-30 | Chiron Corp | Methods of treating cancer and related methods |
TWI335913B (en) | 2002-11-15 | 2011-01-11 | Vertex Pharma | Diaminotriazoles useful as inhibitors of protein kinases |
JP4987232B2 (ja) | 2002-11-18 | 2012-07-25 | ラットガーズ,ザ・ステート・ユニバーシティ・オブ・ニュージャージー | 新規のポリマーを用いた医療用デバイス |
KR101159519B1 (ko) | 2002-11-19 | 2012-06-25 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Rre 및 cte를 포함하는 유전자 작제물 및 조성물 및이의 용도 |
EP1581526B1 (en) | 2002-12-18 | 2009-03-11 | Vertex Pharmaceuticals Incorporated | Benzisoxazole derivatives useful as inhibitors of protein kinases |
AU2004228565A1 (en) | 2003-04-09 | 2004-10-21 | Japan Tobacco Inc. | Heteroaromatic pentacyclic compound and medicinal use thereof |
US7790724B2 (en) | 2003-04-25 | 2010-09-07 | Janssen Pharmaceutica N.V. | c-fms kinase inhibitors |
CA2536964A1 (en) * | 2003-04-25 | 2004-11-11 | Ortho-Mcneil Pharmaceutical, Inc. | C-fms kinase inhibitors |
US20050113566A1 (en) * | 2003-04-25 | 2005-05-26 | Player Mark R. | Inhibitors of C-FMS kinase |
US7427683B2 (en) * | 2003-04-25 | 2008-09-23 | Ortho-Mcneil Pharmaceutical, Inc. | c-fms kinase inhibitors |
CA2533812C (en) | 2003-07-28 | 2012-12-18 | Smithkline Beecham Corporation | Substituted cycloalkylidene compounds |
DK1684750T3 (da) | 2003-10-23 | 2010-08-09 | Ab Science | 2-aminoaryloxazol-forbindelser som tyrosinkinase-inhibitorer |
GB0326601D0 (en) | 2003-11-14 | 2003-12-17 | Novartis Ag | Organic compounds |
BRPI0507271A (pt) | 2004-01-30 | 2007-06-26 | Ab Science | 2-(3-substituìda-aril)amino-4-aril-tiazóis como inibidores de tirosina cinase |
JP4628770B2 (ja) * | 2004-02-09 | 2011-02-09 | 株式会社日立製作所 | 照明装置を備えた画像表示装置及び画像表示方法 |
JP2006084710A (ja) | 2004-09-15 | 2006-03-30 | Toshiba Matsushita Display Technology Co Ltd | 表示制御回路、表示制御方法、および液晶表示装置 |
US20060132383A1 (en) | 2004-09-27 | 2006-06-22 | Idc, Llc | System and method for illuminating interferometric modulator display |
US7662837B2 (en) * | 2004-10-22 | 2010-02-16 | Janssen Pharmaceutica N.V. | Inhibitors of c-fms kinase |
US7705042B2 (en) | 2004-10-22 | 2010-04-27 | Janssen Pharmaceutica Nv | Class of arylamide compounds useful as inhibitors of c-fms kinase |
US7645755B2 (en) | 2004-10-22 | 2010-01-12 | Janssen Pharmaceutical N.V. | Inhibitors of c-fms kinase |
WO2006047277A2 (en) | 2004-10-22 | 2006-05-04 | Janssen Pharmaceutica, N.V. | Inhibitors of c-fms kinase |
JP4904783B2 (ja) | 2005-03-24 | 2012-03-28 | ソニー株式会社 | 表示装置及び表示方法 |
US20060281769A1 (en) | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators |
US20060281700A1 (en) | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators |
US20060281771A1 (en) | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators |
US20060281755A1 (en) | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators |
US20060281788A1 (en) | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor |
AU2006304897B2 (en) | 2005-10-18 | 2012-07-12 | Janssen Pharmaceutica N.V. | Method of inhibiting FLT3 kinase |
NZ594385A (en) | 2005-11-03 | 2013-02-22 | Vertex Pharma | Aminopyrimidines useful as kinase inhibitors |
EP1951716B1 (en) | 2005-11-16 | 2011-05-04 | Vertex Pharmaceuticals, Inc. | Aminopyrimidines useful as kinase inhibitors |
JP4950480B2 (ja) * | 2005-11-22 | 2012-06-13 | 東芝モバイルディスプレイ株式会社 | 液晶表示装置 |
KR100815916B1 (ko) | 2006-02-09 | 2008-03-21 | 엘지.필립스 엘시디 주식회사 | 액정 표시장치의 구동장치 및 구동방법 |
US8697716B2 (en) | 2006-04-20 | 2014-04-15 | Janssen Pharmaceutica Nv | Method of inhibiting C-KIT kinase |
KR101491564B1 (ko) | 2006-04-20 | 2015-02-09 | 얀센 파마슈티카 엔.브이. | C-fms 키나제의 저해제 |
WO2007124316A1 (en) | 2006-04-20 | 2007-11-01 | Janssen Pharmaceutica N.V. | Heterocyclic compounds as inhibitors of c-fms kinase |
EP2687516A1 (en) | 2006-04-20 | 2014-01-22 | Janssen Pharmaceutica N.V. | Inhibitors of C-FMS Kinase |
JP2008096956A (ja) | 2006-09-15 | 2008-04-24 | Olympus Corp | 画像表示方法および画像表示装置 |
JP4479709B2 (ja) * | 2006-10-27 | 2010-06-09 | セイコーエプソン株式会社 | 画像表示装置、画像表示方法、画像表示プログラム、及び画像表示プログラムを記録した記録媒体、並びに電子機器 |
TWI354960B (en) * | 2006-11-07 | 2011-12-21 | Realtek Semiconductor Corp | Method for controlling display device |
JP4285532B2 (ja) | 2006-12-01 | 2009-06-24 | ソニー株式会社 | バックライト制御装置、バックライト制御方法、および液晶表示装置 |
JP5117762B2 (ja) | 2007-05-18 | 2013-01-16 | 株式会社半導体エネルギー研究所 | 液晶表示装置 |
JO3240B1 (ar) | 2007-10-17 | 2018-03-08 | Janssen Pharmaceutica Nv | c-fms مثبطات كيناز |
EP2215482A2 (en) | 2007-10-31 | 2010-08-11 | Janssen Pharmaceutica N.V. | Biomarker for assessing response to fms treatment |
RU2471214C2 (ru) * | 2008-06-27 | 2012-12-27 | Шарп Кабушики Каиша | Устройство управления жидкокристаллическим дисплеем, жидкокристаллический дисплей, способ управления жидкокристаллическим дисплеем, программа и носитель данных |
-
2007
- 2007-04-18 KR KR1020087028189A patent/KR101491564B1/ko active IP Right Grant
- 2007-04-18 KR KR1020087028212A patent/KR101367646B1/ko active IP Right Grant
- 2007-04-18 US US11/736,644 patent/US8859602B2/en active Active
- 2007-04-18 ES ES07760842.0T patent/ES2564781T3/es active Active
- 2007-04-18 JP JP2009506744A patent/JP5331681B2/ja not_active Expired - Fee Related
- 2007-04-18 CA CA2649739A patent/CA2649739C/en active Active
- 2007-04-18 JP JP2009506742A patent/JP5331680B2/ja not_active Expired - Fee Related
- 2007-04-18 EP EP07760846.1A patent/EP2016058B1/en active Active
- 2007-04-18 UA UAA200813399A patent/UA93085C2/ru unknown
- 2007-04-18 BR BRPI0710548A patent/BRPI0710548B8/pt not_active IP Right Cessation
- 2007-04-18 CA CA2649924A patent/CA2649924C/en active Active
- 2007-04-18 NZ NZ572070A patent/NZ572070A/en not_active IP Right Cessation
- 2007-04-18 MX MX2008013529A patent/MX2008013529A/es active IP Right Grant
- 2007-04-18 AU AU2007240440A patent/AU2007240440B2/en not_active Ceased
- 2007-04-18 PE PE2007000480A patent/PE20080074A1/es active IP Right Grant
- 2007-04-18 MX MX2008013530A patent/MX2008013530A/es active IP Right Grant
- 2007-04-18 US US11/736,653 patent/US8815867B2/en active Active
- 2007-04-18 ES ES07760846.1T patent/ES2566772T3/es active Active
- 2007-04-18 EP EP07760840.4A patent/EP2016070B1/en active Active
- 2007-04-18 CN CN200780023190.7A patent/CN101472914B/zh not_active Expired - Fee Related
- 2007-04-18 KR KR1020087028261A patent/KR101406877B1/ko active IP Right Grant
- 2007-04-18 CA CA2650057A patent/CA2650057C/en active Active
- 2007-04-18 EP EP07760842.0A patent/EP2016074B1/en active Active
- 2007-04-18 ES ES07760840.4T patent/ES2565238T3/es active Active
- 2007-04-18 WO PCT/US2007/066870 patent/WO2007124321A1/en active Application Filing
- 2007-04-18 WO PCT/US2007/066875 patent/WO2007124322A1/en active Application Filing
- 2007-04-18 AU AU2007240442A patent/AU2007240442B2/en not_active Ceased
- 2007-04-18 JP JP2009506741A patent/JP5331679B2/ja not_active Expired - Fee Related
- 2007-04-18 RU RU2008145763/04A patent/RU2475483C2/ru active
- 2007-04-18 SG SG201102830-5A patent/SG171593A1/en unknown
- 2007-04-18 US US11/736,650 patent/US8722718B2/en active Active
- 2007-04-18 NZ NZ572072A patent/NZ572072A/en not_active IP Right Cessation
- 2007-04-18 AU AU2007240443A patent/AU2007240443B2/en not_active Ceased
- 2007-04-18 NZ NZ572071A patent/NZ572071A/en not_active IP Right Cessation
- 2007-04-18 WO PCT/US2007/066868 patent/WO2007124319A1/en active Application Filing
- 2007-04-18 MX MX2008013531A patent/MX2008013531A/es active IP Right Grant
- 2007-04-19 TW TW096113732A patent/TW200815415A/zh unknown
- 2007-04-19 AR ARP070101692A patent/AR060611A1/es unknown
- 2007-04-19 AR ARP070101693A patent/AR060612A1/es unknown
- 2007-04-19 TW TW096113731A patent/TW200806659A/zh unknown
- 2007-04-19 UY UY30297A patent/UY30297A1/es active IP Right Grant
- 2007-04-19 AR ARP070101691A patent/AR060610A1/es not_active Application Discontinuation
- 2007-04-19 TW TW096113730A patent/TWI411612B/zh not_active IP Right Cessation
-
2008
- 2008-10-22 IL IL194845A patent/IL194845A/en not_active IP Right Cessation
- 2008-11-19 ZA ZA2008/09873A patent/ZA200809873B/en unknown
- 2008-11-20 NO NO20084896A patent/NO20084896L/no not_active Application Discontinuation
-
2009
- 2009-12-28 HK HK09112210.0A patent/HK1133878A1/xx not_active IP Right Cessation
-
2014
- 2014-03-14 US US14/210,920 patent/US9266866B2/en not_active Expired - Fee Related
- 2014-07-21 US US14/336,014 patent/US9403804B2/en not_active Expired - Fee Related
- 2014-09-09 US US14/480,944 patent/US9394289B2/en not_active Expired - Fee Related
-
2016
- 2016-01-14 US US14/995,644 patent/US20160122334A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009534405A5 (ja) | ||
JP2009534406A5 (ja) | ||
JP2009534407A5 (ja) | ||
RU2008145763A (ru) | Ингибиторы с-fmc киназы | |
JP2014037426A5 (ja) | ||
JP2016520618A5 (ja) | ||
JP2015535832A5 (ja) | ||
JP2008515852A5 (ja) | ||
PT1539753E (pt) | Compostos de pirazolo(3,4-b)piridina e sua utilização como inibidores da fosfodiesterase | |
JP2013510825A5 (ja) | ||
JP2018519323A5 (ja) | ||
JP2008503515A5 (ja) | ||
EP2813509B1 (en) | 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4,3-c]isoquinoline derivatives | |
JP2013532652A5 (ja) | ||
JP2009539848A5 (ja) | ||
JP2011522866A5 (ja) | ||
JP2010513447A5 (ja) | ||
JP2013523802A5 (ja) | ||
JP2016514719A5 (ja) | ||
TW200500364A (en) | Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors | |
JP2014513704A5 (ja) | ||
JP2005507947A5 (ja) | ||
JP2010540593A5 (ja) | ||
JP2011507878A5 (ja) | ||
JP2006528597A5 (ja) |